EAN 2022 | Genetic testing for dystonia

Carlo Colosimo, MD, Santa Maria University Hospital, Terni, Italy, discusses the expanding role of genetics in movement disorders. Recognizing causative genetic defects allows for delineating clinical phenotypes and prognoses and gaining insights into molecular mechanisms and potential therapies. Particularly in dystonia, genome-wide screening will become more critical as genetics have shown to be influential even in patients for whom the role of genetics was considered minimal. This interview took place at the European Academy of Neurology (EAN) 2022 Congress in Vienna, Austria.